Vyleesi® product results: 14% growth in prescriptions dispensed over prior quarter – 7 consecutive quarters of double digit growth.
Click here to learn more ›
Bremelanotide Is Safe and Well-Tolerated in Premenopausal Women With Hypoactive Sexual Desire Disorder (HSDD): Safety Results from the RECONNECT Studies
